AdPEDF gene therapy

N/A

Report date: 2023/10/26 16:56:41

Base Information

Drug NameAdPEDF gene therapy
Drug Alias Name腺病毒介导的色素上皮衍生因子(AdPEDF)基因疗法 （GenVac）Ad35PEDFPEDF gene therapyAd35 adenovector deliveryBlindness prevention programme (GenVac) +[8] 
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionAngiogenesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsMacular DegenerationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNorthwest University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenvec Llc
Active IndicationsN/A
Inactive IndicationsMacular DegenerationDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksN/A